Lymphatic metastasis of bladder cancer: Molecular mechanisms, diagnosis and targeted therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lymphatic metastasis of bladder cancer: Molecular mechanisms, diagnosis and targeted therapy
Authors
Keywords
Lymphangiogenesis, VEGF-C, Noncoding RNA, Molecular diagnostics, Radiomics
Journal
CANCER LETTERS
Volume 505, Issue -, Pages 13-23
Publisher
Elsevier BV
Online
2021-02-19
DOI
10.1016/j.canlet.2021.02.010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer
- (2020) Chanjuan Wang et al. FASEB JOURNAL
- TCF21 promotes luminal-like differentiation and suppresses metastasis in bladder cancer
- (2020) Sharada Mokkapati et al. MOLECULAR CANCER RESEARCH
- circRNA circFUT8 Upregulates Krüpple-like Factor 10 to Inhibit the Metastasis of Bladder Cancer via Sponging miR-570-3p
- (2020) Qingqing He et al. Molecular Therapy-Oncolytics
- Guidelines and definitions for research on epithelial–mesenchymal transition
- (2020) Jing Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer
- (2020) Xu Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR
- (2020) Ruihui Xie et al. MOLECULAR THERAPY
- DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression
- (2019) Ziyue Chen et al. MOLECULAR THERAPY
- Integrated analysis of 18F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer
- (2019) Antoine Girard et al. EUROPEAN RADIOLOGY
- Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM
- (2019) Ruihui Xie et al. CANCER LETTERS
- Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
- (2019) Emil Christensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhanced Primary Tumor Penetration Facilitates Nanoparticle Draining into Lymph Nodes after Systemic Injection for Tumor Metastasis Inhibition
- (2019) Jing Liu et al. ACS Nano
- Management of metastatic bladder cancer
- (2019) Rosa Nadal et al. CANCER TREATMENT REVIEWS
- ARPC4 promotes bladder cancer cell invasion and is associated with lymph node metastasis
- (2019) Ning Xu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy
- (2019) Jonathan E. Rosenberg et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNAs: Key Players in Bladder Cancer
- (2019) Qi Li et al. Molecular Diagnosis & Therapy
- Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence
- (2019) Junming Bi et al. Molecular Cancer
- Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes
- (2019) Jianye Liu et al. Science Advances
- Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation
- (2019) Dong Yan et al. EBioMedicine
- Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study
- (2019) Baris Turkbey et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Clinical Overview of Enfortumab Vedotin in the Management of Locally Advanced or Metastatic Urothelial Carcinoma
- (2019) Kirollos S. Hanna DRUGS
- Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer
- (2019) Changhao Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Nkx2.8 Inhibits Epithelial–Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression ofTwist1
- (2018) Chunping Yu et al. CANCER RESEARCH
- Innate effector cells in angiogenesis and lymphangiogenesis
- (2018) Gilda Varricchi et al. CURRENT OPINION IN IMMUNOLOGY
- Long noncoding RNA BLACAT2 promotes bladder cancer–associated lymphangiogenesis and lymphatic metastasis
- (2018) Wang He et al. JOURNAL OF CLINICAL INVESTIGATION
- A Genomic-clinicopathologic Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer
- (2018) Shao-Xu Wu et al. EBioMedicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
- (2018) Changhao Chen et al. Nature Communications
- Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer
- (2018) Shaoxu Wu et al. EBioMedicine
- Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis
- (2018) Hongwei Liu et al. Molecular Cancer
- Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database
- (2018) Gabriella Del Bene et al. Frontiers in Oncology
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
- (2017) Marko Babjuk et al. EUROPEAN UROLOGY
- CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer
- (2017) Yang Xiong et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Philippe E. Spiess et al. Journal of the National Comprehensive Cancer Network
- Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
- (2017) Daniel P Petrylak et al. LANCET
- Nano-based delivery of RNAi in cancer therapy
- (2017) Yong Xin et al. Molecular Cancer
- Scaling single-cell genomics from phenomenology to mechanism
- (2017) Amos Tanay et al. NATURE
- LncRNA-mediated regulation of cell signaling in cancer
- (2017) W-X Peng et al. ONCOGENE
- A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable
- (2017) Kim E. M. van Kessel et al. PLoS One
- CircRNA: a novel type of biomarker for cancer
- (2017) He-da Zhang et al. Breast Cancer
- Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer
- (2017) Cédric Poyet et al. Oncotarget
- Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel
- (2016) Thomas Seisen et al. EUROPEAN UROLOGY
- Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures
- (2016) Roland Seiler et al. JOURNAL OF UROLOGY
- Current Status of Lymph Node Imaging in Bladder and Prostate Cancer
- (2016) Bernhard Kiss et al. UROLOGY
- MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy
- (2015) Wentao Liu et al. BMC CANCER
- Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer
- (2015) R Matsushita et al. BRITISH JOURNAL OF CANCER
- Diagnosis and Staging of Bladder Cancer
- (2015) Maxine Sun et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients
- (2015) Xi Zhu et al. TUMOR BIOLOGY
- Expression and clinical significance of microRNA-21, maspin and vascular endothelial growth factor-C in bladder cancer
- (2015) HUI-HUI ZHANG et al. Oncology Letters
- miR-128 downregulation promotes growth and metastasis of bladder cancer cells and involves VEGF-C upregulation
- (2015) XU ZHOU et al. Oncology Letters
- A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors
- (2015) David S. Hong et al. Oncotarget
- High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer
- (2015) Cédric Poyet MEDICAL SCIENCE MONITOR
- Preoperative Imaging for Staging Bladder Cancer
- (2015) Maxim J. McKibben et al. Current Urology Reports
- Mechanisms of lymphatic metastasis
- (2014) Sinem Karaman et al. JOURNAL OF CLINICAL INVESTIGATION
- linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer
- (2013) Wang He et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-weighted Magnetic Resonance Imaging Facilitates Detection of Metastases in Normal-sized Pelvic Lymph Nodes of Patients with Bladder and Prostate Cancer
- (2013) Frédéric D. Birkhäuser et al. EUROPEAN UROLOGY
- Pazopanib, a new therapy for metastatic soft tissue sarcoma
- (2013) Jaap Verweij et al. EXPERT OPINION ON PHARMACOTHERAPY
- Lymph node-positive bladder cancer: surgical, pathologic, molecular and prognostic aspects
- (2013) Jose A Pedrosa et al. Expert Review of Anticancer Therapy
- A proteomic study of potential VEGF-C-associated proteins in bladder cancer T24 cells
- (2013) Hui-hui Zhang et al. MEDICAL SCIENCE MONITOR
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- VEGF-D Promotes Tumor Metastasis by Regulating Prostaglandins Produced by the Collecting Lymphatic Endothelium
- (2012) Tara Karnezis et al. CANCER CELL
- Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor-D
- (2012) Kenji Kashima et al. CANCER SCIENCE
- Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis
- (2012) Ramin Shayan et al. CLINICAL & EXPERIMENTAL METASTASIS
- Radiomics: Extracting more information from medical images using advanced feature analysis
- (2012) Philippe Lambin et al. EUROPEAN JOURNAL OF CANCER
- Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer
- (2012) Maria Triantafyllou et al. EUROPEAN JOURNAL OF CANCER
- A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer
- (2012) Joshua J. Meeks et al. EUROPEAN UROLOGY
- Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases
- (2012) M. Shibuya JOURNAL OF BIOCHEMISTRY
- Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma
- (2012) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidermal Growth Factor Facilitates Melanoma Lymph Node Metastasis by Influencing Tumor Lymphangiogenesis
- (2012) Andreas Bracher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The lymphatic system in clinically localized urothelial carcinoma of the bladder: Morphologic characteristics and predictive value
- (2012) Christian Bolenz et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Angiopoietin-1 and -2 Exert Antagonistic Functions in Tumor Angiogenesis, yet Both Induce Lymphangiogenesis
- (2011) E. Fagiani et al. CANCER RESEARCH
- Sonic Hedgehog Pathway Promotes Metastasis and Lymphangiogenesis via Activation of Akt, EMT, and MMP-9 Pathway in Gastric Cancer
- (2011) Y. A. Yoo et al. CANCER RESEARCH
- Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours
- (2011) Achim Fleischmann et al. EUROPEAN UROLOGY
- Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging: A Critical Analysis of the Literature
- (2011) Gianluca Giannarini et al. EUROPEAN UROLOGY
- Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer
- (2011) Tibor Szarvas et al. INTERNATIONAL JOURNAL OF CANCER
- A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment
- (2011) Steven Christopher Smith et al. LANCET ONCOLOGY
- The lymphatic vasculature in disease
- (2011) Kari Alitalo NATURE MEDICINE
- Expression of Hedgehog Pathway Components is Associated with Bladder Cancer Progression and Clinical Outcome
- (2011) Hui-chan He et al. PATHOLOGY & ONCOLOGY RESEARCH
- Lymphangiogenesis: Molecular Mechanisms and Future Promise
- (2010) Tuomas Tammela et al. CELL
- TECHNICAL ARTICLE: Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis
- (2010) N Mir et al. Journal of Medical Imaging and Radiation Oncology
- The Impact of Lymphadenectomy and Lymph Node Metastasis on the Outcomes of Radical Cystectomy for Bladder Cancer
- (2009) Alexander Karl et al. EUROPEAN UROLOGY
- Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth
- (2009) Romulo J C Albuquerque et al. NATURE MEDICINE
- Blocking Neuropilin-2 Function Inhibits Tumor Cell Metastasis
- (2008) Maresa Caunt et al. CANCER CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now